Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Ellis

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Toxicon : Official Journal of the International Society on Toxinology|December 20, 2008
Cytotoxicity and ultrastructural changes in H9c2(2-1) cells treated with pavetamine, a novel polyamineC E Ellis, D Naicker, K M Basson, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 23, 2009
Damage to some contractile and cytoskeleton proteins of the sarcomere in rat neonatal cardiomyocytes after exposure to pavetamineC E Ellis, D Naicker, K M Basson, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 13, 2010
A fluorescent investigation of subcellular damage in H9c2 cells caused by pavetamine, a novel polyamineC E Ellis, D Naicker, K M Basson, et al.
British Journal of Pharmacology|September 28, 1999
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPRD Smart, J C Jerman, S J Brough, et al.
British Journal of Pharmacology|August 28, 1998
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719D R Thomas, S A Gittins, L L Collin, et al.
British Journal of Cancer|October 22, 2009
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesM Toi, H Iwata, Y Fujiwara, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Toxicon : Official Journal of the International Society on Toxinology|December 20, 2008
Cytotoxicity and ultrastructural changes in H9c2(2-1) cells treated with pavetamine, a novel polyamineC E Ellis, D Naicker, K M Basson, et al.
Toxicon : Official Journal of the International Society on Toxinology|December 23, 2009
Damage to some contractile and cytoskeleton proteins of the sarcomere in rat neonatal cardiomyocytes after exposure to pavetamineC E Ellis, D Naicker, K M Basson, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 13, 2010
A fluorescent investigation of subcellular damage in H9c2 cells caused by pavetamine, a novel polyamineC E Ellis, D Naicker, K M Basson, et al.
British Journal of Pharmacology|September 28, 1999
Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell-line using FLIPRD Smart, J C Jerman, S J Brough, et al.
British Journal of Pharmacology|August 28, 1998
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719D R Thomas, S A Gittins, L L Collin, et al.
British Journal of Cancer|October 22, 2009
Lapatinib monotherapy in patients with relapsed, advanced, or metastatic breast cancer: efficacy, safety, and biomarker results from Japanese patients phase II studiesM Toi, H Iwata, Y Fujiwara, et al.
Nature|September 28, 1999
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14R S Ames, H M Sarau, J K Chambers, et al.
Pageof 3